2021
——————
Special Episode (PART 4) - Conversation with KOL Hepatologists and Pharma Thought Leaders in NASH
In this Part 4 podcast, our guests – KOL Hepatologists and Pharma Thought Leaders in NASH – continue their discussions in response to questions by Pharma companies and clinical investigators. Find out their views on how AI Digital Pathology (AI-DP) can effectively impact NASH drug development, preclinical studies and clinical practice with granular histopathological data.
点击链接，收听播客！
Special Episode (PART 4) - Conversation with KOL Hepatologists and Pharma Thought Leaders in NASH
Special Episode (PART 3) - Conversation with KOL Liver Pathologist
We’re bringing you Part 3, where our guests – KOL Hepatologists and Pharma Thought Leaders in NASH – respond to questions by Pharma companies and clinical investigators on how AI Digital Pathology (AI-DP) can augment clinical trial data and work alongside pathologists to detect granular information that could be pivotal for determining patient recruitment, staging and treatment responses.
点击链接，收听播客！
Special Episode (PART 3) - Conversation with KOL Liver Pathologist
Special Episode (PART 2) - Conversation with KOL Liver Pathologist
Our guest KOL liver pathologists continue their conversation from Part 1 following the FDA Webcast, by responding to more questions by Pharma companies and clinical investigators on how AI Digital Pathology (AI-DP) can aid pathologists with precise assessment to better interpret the disease biology of NASH.
点击链接，收听播客！
Special Episode (PART 2) - Conversation with KOL Liver Pathologist
Special Episode (PART 1) - Conversation with KOL Liver Pathologists
In this episode, we speak to Dr. Nikolai Naoumov, MD, PhD, FRCP, FRCPAth, FAASLD (Adviser for Clinical Research and Drug Development in Liver Diseases at Novartis, and physician-scientist and specialist in liver diseases).
点击链接，收听播客！
Special Episode (PART 1) - Conversation with KOL Liver Pathologists
2020
——————Episode 4 with Dr. Nikolai Naoumov - Dialogues on AI Digital Pathology.
In this episode, we speak to Dr. Nikolai Naoumov, MD, PhD, FRCP, FRCPAth, FAASLD (Adviser for Clinical Research and Drug Development in Liver Diseases at Novartis, and physician-scientist and specialist in liver diseases).
点击链接，收听播客！
Episode 4 with Dr. Nikolai Naoumov.mp3
Episode 3 with Dr. Suneil Hosmane - Dialogues on AI Digital Pathology.
Listen to our guest, Dr. Suneil Hosmane (Executive Vice President and Global Head of Diagnostics at GENFIT), as he speaks about the role of AI digital pathology, the latest NIS4 blood-based diagnostic test by Genfit and how AI digital pathology can work with non-invasive technologies (NITs) to enhance drug development efforts in NASH clinical trials today that could ultimately transform the NASH clinical care pathway.
点击链接，收听播客！
Episode 3 with Dr. Suneil Hosmane.mp3
Episode 2 with Dr. David Kleiner feat. Dr. Dean Tai - Dialogues on AI Digital Pathology
In Episode 2 of Dialogues on Digital Pathology, we speak to Dr. David Kleiner, Senior Research Physician and Chief of Post-mortem Section, Laboratory of Pathology, from the Center for Cancer Research at the National Cancer Institute.
点击链接，收听播客！
Episode 2 with Dr. David Kleiner feat. Dr. Dean Tai.mp3
Episode 1 with Dr. Stephen Harrison - Dialogues on AI Digital Pathology
In our inaugural episode of Dialogues on AI Digital Pathology, we speak to Dr Stephen Harrison (Medical Director of Pinnacle Clinical Research) on the role AI digital pathology can play in current NASH drug development.
点击链接，收听播客！
Episode 1 with Dr. Stephen Harrison.mp3
